At Pharma Relief Partners, we are your trusted Patient Advocates, committed to simplifying your healthcare journey. Our mission is to ensure that you receive the medication you need at the most affordable cost, without the added complexities and stress. By working independently from pharmaceutical and insurance companies, we are proud to be on your side, advocating for your health and well-being.
Visit our website: www.pharmareliefpartners.com
call us at 830-217-6711
💊 Top 10 Most Common Brand-Name Prescription Drugs in the U.S.
1. Levothyroxine
* Brand Names: Synthroid, Levoxyl, Unithroid
* Use: Treats hypothyroidism (underactive thyroid)
* 2023 Prescriptions: Approximately 98.97 million
2. Lisinopril
* Brand Names: Prinivil, Zestril
* Use: Treats high blood pressure and heart failure
* 2023 Prescriptions: Approximately 82.51 million
3. Atorvastatin
* Brand Name: Lipitor
* Use: Lowers cholesterol to reduce heart disease risk
* 2022 Prescriptions: Approximately 109.58 million
4. Metformin
* Brand Names: Glucophage, Glumetza, Fortamet
* Use: First-line treatment for type 2 diabetes
* 2022 Prescriptions: Approximately 86.75 million
5. Amlodipine
* Brand Name: Norvasc
* Use: Treats high blood pressure and chest pain (angina)
* 2022 Prescriptions: Approximately 70.77 million
6. Omeprazole
* Brand Names: Prilosec
* Use: Treats gastroesophageal reflux disease (GERD) and ulcers
* 2022 Prescriptions: Approximately 52.13 million
7. Albuterol
* Brand Names: Ventolin HFA, ProAir HFA, Proventil HFA
* Use: Relieves bronchospasm in asthma and COPD
* 2022 Prescriptions: Approximately 59.08 million
8. Gabapentin
* Brand Name: Neurontin
* Use: Treats nerve pain and seizures
* 2023 Prescriptions: Approximately 59.08 million
9. Prednisone
* Brand Names: Deltasone, Orasone
* Use: Reduces inflammation in various conditions
* 2023 Prescriptions: Approximately 59.08 million
10. Alprazolam
* Brand Name: Xanax
* Use: Treats anxiety and panic disorders
* 2023 Prescriptions: Approximately 59.08 million
—
🧬 Other Notable Brand-Name Prescription Drugs
* Humira (Adalimumab)
* Use: Treats autoimmune diseases like rheumatoid arthritis and Crohn’s disease
* 2024 Sales: Approximately $21.23 billion
* Eliquis (Apixaban)
* Use: Anticoagulant for stroke prevention in atrial fibrillation
* 2024 Sales: Approximately $11.78 billion
* Keytruda (Pembrolizumab)
* Use: Cancer immunotherapy for various cancers
* 2024 Sales: Approximately $20.93 billion
* Ozempic (Semaglutide)
* Use: Treats type 2 diabetes and aids in weight loss
* 2024 Sales: Approximately $11.08 billion
* Dupixent (Dupilumab)
* Use: Treats allergic and inflammatory conditions like eczema and asthma
* 2024 Sales: Approximately $11.08 billion
#AffordableMedications #PrescriptionAssistance #patientadvocacy #healthcaresupport #LowerDrugCosts #MedicationSavings #PharmaReliefPartners #PrescriptionHelp #healthequity #affordablehealthcare
source
